AbbVie Inc. (ETR:4AB)
Germany
· Delayed Price · Currency is EUR 168.20
-4.40 (-2.55%)
May 13, 2025, 5:35 PM CET
AbbVie Revenue
AbbVie had revenue of $13.34B USD in the quarter ending March 31, 2025, with 8.39% growth. This brings the company's revenue in the last twelve months to $57.37B, up 5.45% year-over-year. In the year 2024, AbbVie had annual revenue of $56.33B with 3.71% growth.
Revenue (ttm)
$57.37B
Revenue Growth
+5.45%
P/S Ratio
5.69
Revenue / Employee
$1.04M
Employees
55,000
Market Cap
301.93B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 56.33B | 2.02B | 3.71% |
| Dec 31, 2023 | 54.32B | -3.74B | -6.44% |
| Dec 31, 2022 | 58.05B | 1.86B | 3.30% |
| Dec 31, 2021 | 56.20B | 10.39B | 22.69% |
| Dec 31, 2020 | 45.80B | 12.54B | 37.69% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Merck KGaA | 21.16B |
| Siemens Healthineers AG | 23.14B |
| Fresenius SE & Co. KGaA | 22.13B |
| Bayer Aktiengesellschaft | 46.61B |
| Fresenius Medical Care AG | 19.49B |
| Sartorius Aktiengesellschaft | 3.44B |
| Carl Zeiss Meditec AG | 2.08B |
| Fielmann Group AG | 2.33B |
AbbVie News
- 17 hours ago - Techbio Pioneer Etcembly Signs Deal With DJS Antibodies, Part of AbbVie, to Accelerate Antibody Discovery Pipeline - Business Wire
- 20 hours ago - Trump wants to slash U.S. drug prices with 'most favored nation' policy – here's what to know - CNBC
- 23 hours ago - Cerevel Therapeutics Holdings, Inc. Sued for Securities Law Violations - Contact The Gross Law Firm Before June 3, 2025 to Discuss Your Rights – ABBV - GlobeNewsWire
- 23 hours ago - Drugmakers are spared worst-case drug pricing scenario for now - WSJ
- 1 day ago - Trump Declares War On Pharma Drug Pricing, But The Stocks Aren't Tanking - Yet - Seeking Alpha
- 1 day ago - Trump says executive order will slash the cost of prescription drugs - Business Insider
- 1 day ago - Congressional Trading Report: Rep. Jared Moskowitz Bought Over $27K In AbbVie Stock - Benzinga
- 1 day ago - The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Cerevel Therapeutics Holdings, Inc.(ABBV) Shareholders - PRNewsWire